- Home
- BMRN vs Z Comparison
BMRN vs Z Comparison
Compare BMRN & Z Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | Z |
|---|---|---|
| Founded | 1996 | 2004 |
| Country | United States | United States |
| Employees | N/A | 7068 |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 10.4B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | BMRN | Z |
|---|---|---|
| Price | $54.16 | $44.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 26 |
| Target Price | ★ $88.22 | $79.82 |
| AVG Volume (30 Days) | 1.5M | ★ 3.1M |
| Earning Date | 04-24-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.80 | N/A |
| Revenue | ★ $1,313,646,000.00 | N/A |
| Revenue This Year | $15.02 | $17.77 |
| Revenue Next Year | $12.23 | $13.31 |
| P/E Ratio | ★ $29.96 | $499.78 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $50.76 | $39.05 |
| 52 Week High | $66.28 | $93.88 |
Technical Indicators
Market Signals| Indicator | BMRN | Z |
|---|---|---|
| Relative Strength Index (RSI) | 41.40 | 50.80 |
| Support Level | $53.45 | $42.21 |
| Resistance Level | $56.21 | $46.90 |
| Average True Range (ATR) | 1.28 | 1.84 |
| MACD | -0.01 | 0.73 |
| Stochastic Oscillator | 19.32 | 54.26 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About Z Zillow Group Inc. Class C Capital Stock
Zillow Group Inc is a real estate technology company offering a digital platform that connects real estate customers with sellers, agents, loan officers, and other real estate-related professionals. With its tools and resources, Zillow helps real estate professionals grow their businesses, and for renters and housing providers, it offers a marketplace along with a set of end-to-end products and services to streamline applications, leases, payments, and more. The group operates various brands such as Zillow, Zillow Home Loans, Zillow Rentals, Zillow New Construction, Trulia, StreetEasy, Out East, HotPads, Follow Up Boss, ShowingTime, dotloop, and Zillow Closing. Its ecosystem spans the entire home journey from shopping to renting, buying, selling, and financing real estate.